microdosing glp-1 dosage Why Microdosing? A Closer Look at Reported Benefits THE GLP-1 MICRODOSING PROGRAM

Recent research suggests the gut microbiome may also be involved in the development or prevention of adverse reactions to food

Colker et al

supports insulin sensitivity Nervous System: Protects against neurodegeneration and cognitive decline Skin: Improves autoimmune conditions and accelerates wound healing Future Applications of GLP-1 Medications As clinical trials continue, GLP-1 receptor agonists may soon be approved for: Neurodegenerative diseases: Alzheimers, Parkinsons, MS Autoimmune conditions: Psoriasis, RA, Lupus Cardiometabolic syndromes: NAFLD, PCOS, atherosclerosis Pulmonary conditions: Chronic bronchitis, COPD, even long-COVID inflammation Final Thoughts GLP-1 medications are no longer just diabetes or weight loss drugs

doi: 10.1016/j.clnesp.2022.01.030 282

Vitamin B12 absorption: mammalian physiology and acquired and inherited disorders